Histological Findings of Osteomyelitis in Patients with Diabetic Foot and Their Correlation with Radiologic Findings

Article information

Soonchunhyang Med Sci. 2024;30(1):7-12
Publication date (electronic) : 2024 June 30
doi : https://doi.org/10.15746/sms.24.002
1Department of Pathology, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea
2Division of Infectious Diseases, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea
3Department of Orthopaedic Surgery, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea
4Department of Radiology, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea
Correspondence to: In Ho Choi, Department of Pathology, Soonchunhyang University Seoul Hospital, 59 Daesagwan-ro, Yongsan-gu, Seoul 04401, Korea, Tel: +82-2-709-9429, Fax: +82-2-709-9441, E-mail: s78170@schmc.ac.kr
Received 2024 March 26; Accepted 2024 April 29.

Abstract

Objective

Osteomyelitis in patients with diabetic foot has been diagnosed clinically, radiologically, and histologically. However, the accuracy of these diagnostic modalities is not well established. In this study, we histologically reviewed patients who underwent surgical procedures for diabetic foot osteomyelitis and correlated these histological features with radiological findings.

Methods

Eighty patients who were clinically diagnosed with diabetic foot osteomyelitis, who underwent surgical treatment between November 2017 and February 2022, were enrolled. Hematoxylin and eosin-stained slides and radiological findings were reviewed.

Results

Eighty patients were radiologically examined by magnetic resonance imaging (MRI) (49 cases) and/or 99mTc-hexamethyl-propylene amine oxime-labeled white blood cells single-photon emission computed tomography (SPECT)/computed tomography (CT) (65 cases). MRI findings were suggestive of osteomyelitis in 35 cases (71.4%) and soft tissue inflammation in 46 cases (93.8%). In SPECE/CT, 60 cases (92.3%) and 64 cases (98.4%) showed signs of osteomyelitis and soft tissue inflammation, respectively. Histologically, both bone and soft tissue lesions were found in 32 cases (40%), only bone tissue lesions in seven cases (8.8%), and only soft tissue lesions in 40 cases (50%). The sensitivity and specificity of MRI for osteomyelitis were 83.3% (10/12) and 28.6% (4/14), and that of SPECT/CT was 100.0% (12/12) and 12.5% (2/16), respectively. Moreover, those of by MRI findings for soft tissue inflammation were 90.6% (29/32) and 0% (0/12), while that of SPECT/CT was 97.4% (38/39) and 0% (0/18), respectively.

Conclusion

For accurate histological diagnosis of diabetic foot osteomyelitis, sufficient specimens should be obtained. White blood cell SPECT/CT seems to be a more sensitive modality than MRI for the detection of osteomyelitis.

INTRODUCTION

Diabetes mellitus (DM) is associated with several vascular diseases. A significant proportion of individuals with long-standing diabetes develop peripheral neuropathy and peripheral vascular disease. Approximately 25% of people with diabetes experience foot complications at least once in their lifetime [1,2]. Most of these involve infections of the soft tissue. If not appropriately treated, the infection spreads contiguously to the underlying bone and soft tissue, resulting in osteomyelitis of the DM foot. Osteomyelitis of the DM foot is the most common cause of non-traumatic lower-extremity amputations [3]. Therefore, prompt diagnosis and appropriate medical intervention for this condition are crucial to prevent an unfavorable prognosis [4].

Definitive diagnosis of osteomyelitis of the DM foot relies on the detection of distinctive histopathological features and the presence of positive cultures from a sterile bone sample [5]. However, performing a bone biopsy and microbial examination is an invasive procedure that requires time and effort. Thus, imaging studies are being used as an alternative, complementary diagnostic tool for osteomyelitis of the DM foot, because of its low invasiveness and risk. Various panels of modalities, including magnetic resonance imaging (MRI), scintigraphy with 99mTc-hexamethyl-propylene amine oxime (HMPAO)-labeled white blood cells (99mTc-HMPAO WBCs) with single-photon emission computed tomography (SPECT), and 18F-fluorodeoxyglucose positron emission tomography–computed tomography, are available [68]. These diagnostic tools have shown high sensitivity and specificity in several individual studies and meta-analyses [913].

Currently, both histological and radiological findings are used as diagnostic criteria for osteomyelitis [5]. In addition to positive histology, with positive bone culture, and purulence in the bone found during surgery, detached bone fragments removed from the ulcer and intraosseous abscess found on MRI are definitive findings for the diagnosis of osteomyelitis of the DM foot.

However, the accuracy of these diagnostic radiologic modalities, as well as the correlation of these radiological findings with pathological examination, has not been well established. In the present study, we histologically and radiologically reviewed patients who underwent surgical procedures for DM foot osteomyelitis.

MATERIALS AND METHODS

Eighty patients who were clinically diagnosed with DM foot osteomyelitis in the single medical center, who underwent surgical treatment, such as bone excision and biopsy, amputation, or soft tissue excision between March 2017 and February 2022, were enrolled. Hematoxylin and eosin slides and radiological findings from MRI and 99mTc-HMPAO WBC SPECT/computed tomography (CT) were reviewed.

Osteomyelitis was histologically confirmed when the specimen included bone necrosis, acute inflammation or abscess formation, chronic inflammation (fibrosis), or indications of reparative processes in the marrow space or bone tissue. Soft tissue inflammation (STI) was histologically confirmed when the specimen showed acute or chronic inflammation, fibrosis, or abscess formation. Representative images of pathologic findings are shown in Fig. 1. On MRI, osteomyelitis was suggested if there was increased signal intensity and enhancement in the bone marrow. On WBC SPECT/CT, osteomyelitis was suggested if there was abnormal radioactive leukocyte accumulation in the soft tissue extending to the bone.

Fig. 1

Representative images of pathology specimen. (A, B) A case showing both osteomyelitis and soft tissue inflammation. Acute inflammatory cell infiltration is noted in left side (soft tissue, blue arrow) and marrow space (right side, red arrow) (hematoxylin and eosin [H&E], ×40 and ×100). (C) A case showing bone necrosis. Acellular bone trabeculae and marrow space is noted (H&E, ×100). (D) A case showing no definite evidence of osteomyelitis and soft tissue inflammation. Mildly degenerated bony trabeculae is noted (H&E, ×100).

Sensitivity was defined as the probability of positive cases on imaging tests among cases diagnosed with osteomyelitis on biopsy. Specificity was defined as the probability of negative results among cases that were negative for osteomyelitis on biopsy.

This retrospective study was approved by the Institutional Review Board of Soonchunhyang University Seoul Hospital (approval no., 2023-02-009), and informed consent from individual participants was waived because of the retrospective design of this study.

RESULTS

The patients were radiologically examined by MRI (49/80, 61.3%) and/or WBC SPECT/CT (65/80, 81.3%). Forty patients underwent both MRI and SPECT/CT. The MRI findings were suggestive of osteomyelitis in 35 patients (35/49, 71.4%) and of STI in 46 patients (46/49, 93.8%). The SPECT/CT findings indicated osteomyelitis in 60 patients (60/65, 92.3%) and STI in 64 patients (64/65, 98.4%). A summary of the results is presented in Table 1.

Comparison of diagnostic modalities in diabetes mellitus foot osteomyelitis cases

Histologically, both bone and soft tissue involvement was found in 32/80 patients (40%), bone tissue involvement only in 7/80 patients (8.8%), and soft tissue involvement only in 40/80 patients (50%). A summary of the results is presented in Table 2. Among the 32 cases in which both bone and soft tissue were involved, 11 cases had both osteomyelitis and STI (34.4%), three had osteomyelitis only (9.4%), and six had STI only (18.8%).

Evaluation of the adequacy of pathological specimen

Of the abovementioned 32 patients, 22 and 21 underwent MRI and SPECT/CT, respectively. Among these patients who underwent MRI, 17 (17/22, 77.2%) and 21 (21/22, 95.5) showed findings suggestive of osteomyelitis and STI, respectively. In contrast, in patients who underwent SPECT/CT, 19 (19/21, 90.5%) and 21 (21/21, 100%) showed findings suggestive of osteomyelitis and STI, respectively. A summary of the results is presented in Table 3.

Comparison of diagnostic modalities of MRI and WBC SPECT/CT

The sensitivity and specificity of MRI findings for diagnosing osteomyelitis were 83.3% (10/12) and 28.6% (4/14), respectively. For WBC SPECT/CT, the corresponding values were 100% (12/12) and 12.5% (2/16), respectively. The sensitivity and specificity of MRI for STI were 90.6% (29/32) and 0% (0/12), respectively. In WBC SPECT/CT, the corresponding values were 97.4% (38/39) and 0% (0/18).

The positive-predictive value (PPV) of MRI for osteomyelitis was 50.0% (10/20), and that of SPECT/CT was 46.2% (12/26). In contrast, the PPV of MRI for STI was 70.7% (29/41), and that of SPECT/CT was 67.9% (38/56). Representative MRI and WBC SPECT/CT images are shown in Fig. 2. A summary of the results is presented in Table 4.

Fig. 2

Magnetic resonance imaging (MRI) and white blood cell single-photon computed tomography/computed tomography (WBC SPECT/CT) images of a specimen. (A) WBC SPECT/CT shows intense leukocyte accumulation in the lateral aspect of the left foot and left toe; (B) MRI shows diffuse T1 low signal intensity change in the left second toe, with bone destruction changes, suggestive of diabetic foot osteomyelitis.

Diagnostic statistics of diagnostic modalities of MRI and WBC SPEC/CT

DISCUSSION

This pilot study reviewed the concurrent histological and radiological findings of patients with osteomyelitis and/or soft tissue inflammation of the DM foot and sought to identify the validity of MRI and WBC SPECT/CT diagnosis based on correlations with histological findings. We found that the PPV of MRI for osteomyelitis was 50.0%, while that of WBC SPECT/CT was 46.2%. The PPV of MRI for STI was 70.7%, while that of WBC SPECT/CT was 67.9%. Consequently, histological examination, based on sufficient specimens, remains important for the diagnosis of DM foot osteomyelitis, although imaging modalities may be useful adjunctive tools. In particular, the sensitivity of WBC SPECT/CT exceeded that of MRI.

Although various imaging tools with high accuracy have been developed, histological examination has been considered the gold standard for the diagnosis of DM foot osteomyelitis [14]. In addition, to determine the causative pathogen for appropriate antibiotic treatment, it is necessary to obtain evidence of bacterial growth in bone cultures. Therefore, accurate histological evaluation is important.

Imaging modalities are convenient and noninvasive. In particular, MRI has been the imaging mainstay for diagnosing osteomyelitis and has the advantage of not involving radiation exposure. However, people with claustrophobia may find it difficult to tolerate the long test times involved in MRI. In addition, patients with implanted electrical devices or metallic materials cannot undergo MRI. On the other hand, WBC SPECT/CT exposes the patient to radiation. Another disadvantage of imaging studies is the lack of complete differentiation from Charcot neuropathic arthropathy [15].

In this study, the positive diagnosis rate of osteomyelitis on histological examination was 43.8% (14/32). In other studies, the positive diagnosis rate by histological examination ranged from 23.4% to 88.5%, with an average of 55.5% [1012,1627]. The sensitivity, specificity, and PPV of osteomyelitis diagnosis by MRI, matched by histological examination results, were 83.3%, 28.6%, and 50.0%, respectively. With WBC SPECT/CT, the corresponding values were 100%, 12.5%, and 46.2%, respectively. Compared with other studies, the sensitivity of MRI ranged from 29% to 100%, with an average of 81%. In terms of specificity, the corresponding values were 37% to 100% (68.5%), and the PPV values were 50% to 81.8% (72.4%) [10,1622]. For WBC SPECT/CT, the previously reported sensitivity ranged from 88% to 100%, with an average of 90.7%. For specificity, the corresponding values were 35% to 100% (84.5%), and the PPV was 73.8% to 100% (91.2%).

The low positive diagnosis rate of histological examination in this study increased the false-positive rate of imaging modalities, which affects the specificity and PPV. The cause of this result may be the application of strict diagnostic criteria, using histological examination only, or the acquisition of inappropriate tissue sections due to insufficient decalcification.

This study had some limitations. Because of the retrospective nature of the study, the methods of specimen acquisition, slide creation, and image data could not be controlled. In future, a prospective study using matched imaging studies and tissue sampling should be performed. However, the present study was meaningful in that it proved the diagnostic usefulness of MRI and 99mTc-HMPAO WBC SPECT/CT by analyzing a number of samples and confirming that these are mutually complementary diagnostic tools. Less than half of the pathological samples from the clinical DM foot patients in this study contained both bone and soft tissue. Only half of the patients underwent MRI or WBC SPECT/CT. Finally, the proportion of cases in which it was possible to evaluate the concordance between imaging study and histologic evaluation was smaller than that in the cohort.

In conclusion, accurate histological diagnosis of DM foot osteomyelitis is important, and sufficient specimens should be secured. According to the guidelines on the diagnosis and treatment of foot infections in persons with diabetes, when osteomyelitis of a DM foot is suspected, a combination of the probe-to-bone test, erythrocyte sedimentation rate, and plain radiography is used for initial studies. If a diagnosis of osteomyelitis of a DM foot is doubtful based on these evaluations, advanced imaging studies, such as MRI and WBC SPECT/CT can be considered [27]. In a study by Meyr et al. [28] on the level of agreement using a multi-test approach for the diagnosis of DM foot osteomyelitis, the interobserver or inter-test agreement was low for tests commonly used for the diagnosis of osteomyelitis of the DM foot (range, 42%–62%). These results show that objective standard criteria for accurate diagnosis of DM foot osteomyelitis have not yet been established. Further research is required to achieve a consensus. We expect that this study will contribute to the establishment of better standards for the diagnosis of DM foot osteomyelitis. Our results indicate that WBC SPECT/CT may be a more sensitive modality than MRI for the detection of osteomyelitis of the DM foot.

Notes

No potential conflict of interest relevant to this article was reported.

FUNDING

This study was supported by the Soonchunhyang University Research Fund.

References

1. Markakis K, Bowling FL, Boulton AJ. The diabetic foot in 2015: an overview. Diabetes Metab Res Rev 2016;32Suppl 1. :169–78.
2. Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Ann Med 2017;49:106–16.
3. Brennan MB, Hess TM, Bartle B, Cooper JM, Kang J, Huang ES, et al. Diabetic foot ulcer severity predicts mortality among veterans with type 2 diabetes. J Diabetes Complications 2017;31:556–61.
4. Lavery LA, Armstrong DG, Wunderlich RP, Mohler MJ, Wendel CS, Lipsky BA. Risk factors for foot infections in individuals with diabetes. Diabetes Care 2006;29:1288–93.
5. Berendt AR, Peters EJ, Bakker K, Embil JM, Eneroth M, Hinchliffe RJ, et al. Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment. Diabetes Metab Res Rev 2008;24Suppl 1. :S145–61.
6. Palestro CJ, Love C. Nuclear medicine and diabetic foot infections. Semin Nucl Med 2009;39:52–65.
7. Israel O, Sconfienza LM, Lipsky BA. Diagnosing diabetic foot infection: the role of imaging and a proposed flow chart for assessment. Q J Nucl Med Mol Imaging 2014;58:33–45.
8. Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2012;54:e132–73.
9. Lauri C, Tamminga M, Glaudemans AW, Juarez Orozco LE, Erba PA, Jutte PC, et al. Detection of osteomyelitis in the diabetic foot by imaging techniques: a systematic review and meta-analysis comparing MRI, white blood cell scintigraphy, and FDG-PET. Diabetes Care 2017;40:1111–20.
10. Nawaz A, Torigian DA, Siegelman ES, Basu S, Chryssikos T, Alavi A. Diagnostic performance of FDG-PET, MRI, and plain film radiography (PFR) for the diagnosis of osteomyelitis in the diabetic foot. Mol Imaging Biol 2010;12:335–42.
11. Filippi L, Uccioli L, Giurato L, Schillaci O. Diabetic foot infection: usefulness of SPECT/CT for 99mTc-HMPAO-labeled leukocyte imaging. J Nucl Med 2009;50:1042–6.
12. Georga S, Manes C, Lo-Presti D, Mpalaris V, Tsavdaridis I, Iakovou I, et al. SPECT/CT value in the diagnosis of diabetic foot infections by 99mTc-HMPAO-labeled leucocyte scan. Eur J Nucl Med Mol Imaging 2015;42:S790–1.
13. Yang H, Zhuang H, Rubello D, Alavi A. Mild-to-moderate hyperglycemia will not decrease the sensitivity of 18F-FDG PET imaging in the detection of pedal osteomyelitis in diabetic patients. Nucl Med Commun 2016;37:259–62.
14. Lipsky BA, Peters EJ, Senneville E, Berendt AR, Embil JM, Lavery LA, et al. Expert opinion on the management of infections in the diabetic foot. Diabetes Metab Res Rev 2012;28Suppl 1. :163–78.
15. Kucera T, Shaikh HH, Sponer P. Charcot neuropathic arthropathy of the foot: a literature review and single-center experience. J Diabetes Res 2016;2016:3207043.
16. Levine SE, Neagle CE, Esterhai JL, Wright DG, Dalinka MK. Magnetic resonance imaging for the diagnosis of osteomyelitis in the diabetic patient with a foot ulcer. Foot Ankle Int 1994;15:151–6.
17. Newman LG, Waller J, Palestro CJ, Hermann G, Klein MJ, Schwartz M, et al. Leukocyte scanning with 111In is superior to magnetic resonance imaging in diagnosis of clinically unsuspected osteomyelitis in diabetic foot ulcers. Diabetes Care 1992;15:1527–30.
18. Croll SD, Nicholas GG, Osborne MA, Wasser TE, Jones S. Role of magnetic resonance imaging in the diagnosis of osteomyelitis in diabetic foot infections. J Vasc Surg 1996;24:266–70.
19. Kearney T, Robinson S, Elkeles RS, Pointin K, Cunningham D, Gedroyc W. The detection of pedal osteomyelitis in diabetic patients. Pract Diabetes Int 1999;16:98–100.
20. Ertugrul MB, Baktiroglu S, Salman S, Unal S, Aksoy M, Berberoglu K, et al. The diagnosis of osteomyelitis of the foot in diabetes: microbiological examination vs. magnetic resonance imaging and labelled leucocyte scanning. Diabet Med 2006;23:649–53.
21. Zorkaltsev M, Zavadovskaya V, Udodov V, Zamyshevskaya M, Grigoryev E, Kurazhov A. Radiolabeled WBC-scintigraphy versus magnetic resonance imaging and bone scintigraphy in diabetic patients with suspected osteomyelitis of the foot. Eur J Nucl Med Mol Imaging 2014;41:S590–1.
22. La Fontaine J, Bhavan K, Lam K, Van Asten S, Erdman W, Lavery LA, et al. Comparison between Tc-99m WBC SPECT/CT and MRI for the diagnosis of biopsy-proven diabetic foot osteomyelitis. Wounds 2016;28:271–8.
23. Devillers A, Moisan A, Hennion F, Garin E, Poirier JY, Bourguet P. Contribution of technetium-99m hexamethylpropylene amine oxime labelled leucocyte scintigraphy to the diagnosis of diabetic foot infection. Eur J Nucl Med 1998;25:132–8.
24. Familiari D, Glaudemans AW, Vitale V, Prosperi D, Bagni O, Lenza A, et al. Can sequential 18F-FDG PET/CT replace WBC imaging in the diabetic foot? J Nucl Med 2011;52:1012–9.
25. Harvey J, Cohen MM. Technetium-99-labeled leukocytes in diagnosing diabetic osteomyelitis in the foot. J Foot Ankle Surg 1997;36:209–14.
26. Przybylski MM, Holloway S, Vyce SD, Obando A. Diagnosing osteomyelitis in the diabetic foot: a pilot study to examine the sensitivity and specificity of Tc(99m) white blood cell-labelled single photon emission computed tomography/computed tomography. Int Wound J 2016;13:382–9.
27. Unal SN, Birinci H, Baktiroglu S, Cantez S. Comparison of Tc-99m methylene diphosphonate, Tc-99m human immune globulin, and Tc-99m-labeled white blood cell scintigraphy in the diabetic foot. Clin Nucl Med 2001;26:1016–21.
28. Meyr AJ, Seo K, Khurana JS, Choksi R, Chakraborty B. Level of agreement with a multi-test approach to the diagnosis of diabetic foot osteomyelitis. J Foot Ankle Surg 2018;57:1137–9.

Article information Continued

Funded by : Soonchunhyang University Research Fund
Funding : This study was supported by the Soonchunhyang University Research Fund

Fig. 1

Representative images of pathology specimen. (A, B) A case showing both osteomyelitis and soft tissue inflammation. Acute inflammatory cell infiltration is noted in left side (soft tissue, blue arrow) and marrow space (right side, red arrow) (hematoxylin and eosin [H&E], ×40 and ×100). (C) A case showing bone necrosis. Acellular bone trabeculae and marrow space is noted (H&E, ×100). (D) A case showing no definite evidence of osteomyelitis and soft tissue inflammation. Mildly degenerated bony trabeculae is noted (H&E, ×100).

Fig. 2

Magnetic resonance imaging (MRI) and white blood cell single-photon computed tomography/computed tomography (WBC SPECT/CT) images of a specimen. (A) WBC SPECT/CT shows intense leukocyte accumulation in the lateral aspect of the left foot and left toe; (B) MRI shows diffuse T1 low signal intensity change in the left second toe, with bone destruction changes, suggestive of diabetic foot osteomyelitis.

Table 1

Comparison of diagnostic modalities in diabetes mellitus foot osteomyelitis cases

Variable Bone involvement Soft tissue involvement
MRI 35/49 (71.4) 46/49 (93.8)
WBC SPECT/CT 60/65 (92.3) 64/65 (98.4)

Values are presented as number (%).

MRI, magnetic resonance imaging; WBC, white blood cell; SPECT/CT, single-photon emission computed tomography/computed tomography.

Table 2

Evaluation of the adequacy of pathological specimen

Variable No. (%)
Includes both bone and soft tissue 32 (40.0)
Bone tissue only 7 (8.8)
Soft tissue only 40 (50.0)
Not applicable 1 (1.2)
Total 80 (100.0)

Table 3

Comparison of diagnostic modalities of MRI and WBC SPECT/CT

Radiologic results Category Histologic presence of inflammation

Positive Negative Total
MRI
 Osteomyelitis Positive 10 10 20
Negative 2 4 6
Total 12 14 26
 Soft tissue inflammation Positive 29 12 41
Negative 3 0 3
Total 32 12 44

WBC SPECT/CT
 Osteomyelitis Positive 12 14 26
Negative 0 2 2
Total 12 16 28
 Soft tissue inflammation Positive 38 18 56
Negative 1 0 1
Total 39 18 57

Values are presented as number.

MRI, magnetic resonance imaging; WBC, white blood cell; SPECT/CT, single-photon emission computed tomography/computed tomography.

Table 4

Diagnostic statistics of diagnostic modalities of MRI and WBC SPEC/CT

Diagnostic statistic MRI WBC SPECT/CT


Osteomyelitis Soft tissue inflammation Osteomyelitis Soft tissue inflammation
PPV 50.0 70.7 46.2 67.9

NPV 66.6 0 100.0 0

Sensitivity 83.3 90.6 100.0 97.4

Specificity 28.6 0 12.5 0

Values are presented as %.

MRI, magnetic resonance imaging; WBC, white blood cell; SPECT/CT, single-photon emission computed tomography/computed tomography; PPV, positive predictive value; NPV, negative predictive value.